This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

My Cart
Shopping Cart
0 items
View Cart

Animal Pharm Veterinary Vaccines Report 2015


Availability: In stock

SKU: 77121

Quick Overview

Markets, products, regulation, technology, and future prospects

Click on image to zoom

You may also be interested in ...

Product Overview

This comprehensive report covers animal health vaccine products for poultry, cattle, sheep, goats, horses, pigs, and companion animals (cats and dogs).

It looks at the growth and development of the global vaccines market and the factors driving these trends, such as increased animal production, consumption and trade.

The key role of the global animal health companies is examined in detail, and there are also special sections on emerging markets in China and Africa.

The report goes on to consider the development of vaccine technology, particularly in response to new disease threats.

Specialist case studies on influenza, foot and mouth disease, porcine epidemic diarrhoea virus, and aquaculture are also covered in a separate chapter.

The regulatory chapter covers Europe, the US, Canada, Japan, China, South East Asia, Australia, New Zealand, Latin America, and Africa.

The report concludes by looking at future growth trends - unmet needs, new therapeutic areas, food safety vaccines, and the potential for improvements to existing veterinary vaccines.

To find out more view a video Video

*PLEASE NOTE: Price is for Single User License only. For multi-user deals please email

Published: September 2014

Features & Contents

This report will help you understand::

  • Which animal health vaccine products are available?
  • What are the current and future trends in the global animal health vaccines market?
  • What is the role of emerging economies?
  • What are the new types of animal health vaccine technology?
  • Which animal diseases may be affected by these developments?
  • What regulation is implemented in this market?

Click here for contents pages

Click here for the executive summary

Click here for sample pages

More Info

Professor Andy Peters is a Director of ARPEXAS Ltd., an animal health consultancy, providing support to the industry and academia in strategies for new product development, with special emphasis on vaccines and diagnostics in both developed and developing countries.

Until December 2005 he was Head of European Vaccine R&D with Pfizer Animal Health. Between 1993 and 1998 he was Professor of Animal Health and Production at the Royal Veterinary College, London.

He is a veterinarian with PhD and DSc degrees in animal science and currently holds a special professorship with the University of Nottingham.

Reviews (0)

There are no reviews for this product yet. Be the first to share your experiences.

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.
By continuing to use the website, you consent to our use of cookies.